DoubleVerify to Participate in Upcoming Investor Conferences

DoubleVerify to Participate in Upcoming Investor Conferences GlobeNewswire February 04, 2026 NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) — DoubleVerify (“DV”) (NYSE: DV), a leading software platform for digital media measurement, data and analytics, today announced that Mark Zagorski, CEO, and Nicola Allais, CFO, will participate in the following investor conferences: The Citizens Technology Conference […]

Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026

Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026 GlobeNewswire February 04, 2026 CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in a

Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026 GlobeNewswire February 04, 2026 REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company's chief executive

ARRAY Technologies Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

ARRAY Technologies Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call GlobeNewswire February 04, 2026 ALBUQUERQUE, N.M., Feb. 04, 2026 (GLOBE NEWSWIRE) — ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (NASDAQ: ARRY), a leading global provider of solar tracking technology products, software, services and foundation solutions, today announced that the Company

Lesaka’s Q2 FY2026 Results: Lesaka achieves mid-point of its profitability guidance and reaffirms its FY2026 full year guidance

Lesaka's Q2 FY2026 Results: Lesaka achieves mid-point of its profitability guidance and reaffirms its FY2026 full year guidance GlobeNewswire February 04, 2026 JOHANNESBURG, Feb. 04, 2026 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the second quarter of fiscal 2026 (“Q2 2026”). Q2 2026 performance1:All growth rates are year-on-year

IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026

IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026 GlobeNewswire February 04, 2026 ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market opens on

Bel Fuse Schedules Fourth Quarter 2025 Financial Results Conference Call

Bel Fuse Schedules Fourth Quarter 2025 Financial Results Conference Call GlobeNewswire February 04, 2026 WEST ORANGE, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) — Bel Fuse Inc. (Nasdaq: BELFA and BELFB), a designer, manufacturer, and provider of products that power, protect and connect electronic circuits, today announced plans to release preliminary financial results for the fourth

Insurance Expert Glenda Martinez of Silver Spring, MD Explains Homeowners Insurance Declarations Page for HelloNation

SILVER SPRING, Md., Feb. 04, 2026 (GLOBE NEWSWIRE) — What is the homeowners' insurance declarations page, and why should policyholders actually read it? A HelloNation article provides the answer by outlining exactly what this document contains and how it can help homeowners make informed decisions about their coverage. The article focuses on the often-overlooked details

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

(NASDAQ:LFVN), SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025. Second Quarter Fiscal 2026 Summary*: Revenue was $48.9 million, a

Scroll to Top